ARCHIVES

Pazdur: Registration Trials Run By Groups Need Same Rigor As Industry Trials

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

In Congress: HHS Funding Bill Vetoed, Congress, White House Negotiating on Budget

November 12, 1999

Move Starts To Strip Anticancer Drug Regulation From FDA After New Charges It Is Delaying INDs

October 15, 1976

UPCI Clarifies Agreement Between Eli Lilly And PCRN.

July 27, 2001

Nexavar Approved For Patients With Inoperable Liver Cancer

November 30, 2007

Drugs and Targets: Cyramza approved in metastatic stomach cancer

November 7, 2014

Remarks on HPV Vaccines, SPORE Funds Create Controversy for NCI’s John Niederhuber.

April 14, 2006